SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Etienne M. Sokal, Massimiliano Paganelli, Stefan Wirth, Piotr Socha, Pietro Vajro, Florence Lacaille, Deirdre Kelly, Giorgina Mieli-Vergani, Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines, Journal of Hepatology, 2013, 59, 4, 814

    CrossRef

  2. 2
    Pietro Vajro, Claudio Veropalumbo, Sergio Maddaluno, Mariacarolina Salerno, Giancarlo Parenti, Claudio Pignata, Treatment of children with chronic viral hepatitis: what is available and what is in store, World Journal of Pediatrics, 2013, 9, 3, 212

    CrossRef

  3. 3
    Massimiliano Paganelli, Xavier Stephenne, Etienne M. Sokal, Chronic hepatitis B in children and adolescents, Journal of Hepatology, 2012, 57, 4, 885

    CrossRef

  4. 4
    Elizabeth Boxall, Jaswant Sira, Shamima Kaskar, Judith Workman, Deirdre Kelly, Does genotype predict response to treatment in children infected with hepatitis B perinatally?, Journal of Medical Virology, 2012, 84, 10
  5. 5
    Akshay Kapoor, Vidyut Bhatia, Sarath Gopalan, Anupam Sibal, Hepatitis B in children—current status, Apollo Medicine, 2011, 8, 4, 287

    CrossRef

  6. 6
    Jessi Erlichman, Barbara A. Haber, Update on the Management of Pediatric Chronic Hepatitis B, Current Hepatitis Reports, 2011, 10, 2, 112

    CrossRef

  7. 7
    Matthew J. Giefer, Karen F. Murray, Immune-Tolerant Hepatitis B Infection: To Treat or Not to Treat?, Current Hepatitis Reports, 2010, 9, 2, 60

    CrossRef

  8. 8
    Uzma Shah, Deirdre Kelly, Mei-Hwei Chang, Tomoo Fujisawa, Solange Heller, Regino P González-Peralta, Paloma Jara, Giorgina Mieli-Vergani, Neelam Mohan, Karen F Murray, Management of Chronic Hepatitis B in Children, Journal of Pediatric Gastroenterology and Nutrition, 2009, 48, 4, 399

    CrossRef

  9. 9
    Karen F Murray, Uzma Shah, Neelam Mohan, Solange Heller, Regino P González-Peralta, Deirdre Kelly, Mei-Hwei Chang, Giorgina Mieli-Vergani, Paloma Jara, Tomoo Fujisawa, Chronic Hepatitis, Journal of Pediatric Gastroenterology and Nutrition, 2008, 47, 2, 225

    CrossRef

  10. 10
    Mei-Hwei Chang, Natural history and clinical management of chronic hepatitis B virus infection in children, Hepatology International, 2008, 2, S1, 28

    CrossRef

  11. 11
    Teerha Piratvisuth, Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B, Hepatology International, 2008, 2, 2, 140

    CrossRef

  12. 12
    Anna S. F. Lok, Brian J. McMahon, Chronic hepatitis B, Hepatology, 2007, 45, 2
  13. 13
    Mei-Hwei Chang, Hepatitis B virus infection, Seminars in Fetal and Neonatal Medicine, 2007, 12, 3, 160

    CrossRef

  14. 14
    Zarife Kuloğlu, Ceyda Tuna Krsaçloğlu, Aydan Kansu, Esra Erden, Nurten Girgin, Liver Histology of Children With Chronic Hepatitis Treated With Interferon-α Alone or in Combination With Lamivudine, Journal of Pediatric Gastroenterology and Nutrition, 2007, 45, 5, 564

    CrossRef

  15. 15
    Lorenzo D’Antiga, Marion Aw, Mark Atkins, Alison Moorat, Diego Vergani, Giorgina Mieli-Vergani, Combined lamivudine/interferon-α treatment in ‘immunotolerant’ children perinatally infected with hepatitis B: A pilot study, The Journal of Pediatrics, 2006, 148, 2, 228

    CrossRef

  16. 16
    Elizabeth H. Boxall, Jaswant Sira, Anna L. Ballard, Paul Davies, Deirdre A. Kelly, Long-term follow-up of hepatitis B carrier children treated with interferon and prednisolone, Journal of Medical Virology, 2006, 78, 7
  17. 17
    Nanda Kerkar, Hepatitis B in children: Complexities in management, Pediatric Transplantation, 2005, 9, 5
  18. 18
    Dariusz M. Lebensztejn, Maria E. Sobaniec-Łotowska, Michael Bauer, Maciej Kaczmarski, Michael Voelker, Detlef Schuppan, Serum fibrosis markers as predictors of an antifibrotic effect of interferon alfa in children with chronic hepatitis B, European Journal of Gastroenterology & Hepatology, 2005, 17, 8, 843

    CrossRef

  19. 19
    L. M. Mofenson, J. Oleske, L. Serchuck, R. Van Dyke, C. Wilfert, Treating Opportunistic Infections among HIV-Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America, Clinical Infectious Diseases, 2005, 40, Supplement 1, S1

    CrossRef

  20. 20
    Flavia Bortolotti, Treatment of chronic hepatitis B in children, Journal of Hepatology, 2003, 39, 200

    CrossRef

  21. 21
    Mukadder AyŞe SelimoĞlu, Sema AydoĞdu, Fatih Ünal, AyŞin ZeytinoĞlu, Gül Yüce, RaŞit Vural YaĞci, Alpha interferon and lamivudine combination therapy for chronic hepatitis B in children, Pediatrics International, 2002, 44, 4
  22. 22
    Herwig Lackner, Andrea Moser, Martin Benesch, Johann Deutsch, Harald H Kessler, Reinhold Kerbl, Wolfgang Schwinger, Hans-Jürgen Dornbusch, Petra Sovinz, Christian Urban, Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy, Journal of Clinical Virology, 2002, 25, 73

    CrossRef

  23. 23
    M. Lindh, C. Hannoun, P. Horal, K. Krogsgaard, Virological response to interferon therapy of chronic hepatitis B as measured by a highly sensitive assay, Journal of Viral Hepatitis, 2001, 8, 5
  24. 24
    Osamu Yokosuka, Role of steroid priming in the treatment of chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2000, 15,
  25. 25
    Comanor, Minor, Conjeevaram, Roberts, Alvarez, Bern, Goyens, Rosenthal, Lachaux, Shelton, Sarles, Sokal, Statistical models for predicting response to interferon-α and spontaneous seroconversion in children with chronic hepatitis B, Journal of Viral Hepatitis, 2000, 7, 2
    Direct Link:
  26. 26
    Vicky Lee Ng, William F. Balistreri, HEPATITIS B, Clinics in Liver Disease, 1999, 3, 2, 267

    CrossRef

  27. 27
    Paloma Jara, Flavia Bortolotti, Interferon-α Treatment of Chronic Hepatitis B in Childhood: A Consensus Advice Based on Experience in European Children, Journal of Pediatric Gastroenterology and Nutrition, 1999, 29, 2, 163

    CrossRef

  28. 28
    G. Maggiore, S. Caprai, Quand traiter par l'interféron un enfant atteint d'hépatite chronique B?, Archives de Pédiatrie, 1999, 6, S174

    CrossRef

  29. 29
    RAFFAELE IORIO, PASQUALINA PENSATI, SALVATORE BOTTA, SABINO MOSCHELLA, NICOLA IMPAGLIAZZO, PIETRO VAJRO, ANGELA VEGNENTE, Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis, The Pediatric Infectious Disease Journal, 1997, 16, 10, 984

    CrossRef

  30. 30
    Norah A. Terrault, Treatment of Chronic Hepatitis B and Chronic Hepatitis C, Reviews in Medical Virology, 1996, 6, 4
  31. 31
    Jesper Brok, Martin Thyge Mellerup, Kim Krogsgaard, Christian Gluud, Glucocorticosteroids for viral hepatitis C, The Cochrane Library,
  32. 32
    Asbjørn Hróbjartsson, Peter C Gøtzsche, Placebo interventions for all clinical conditions, The Cochrane Library,
  33. 33
    Asbjørn Hróbjartsson, Peter C Gøtzsche, Placebo interventions for all clinical conditions, The Cochrane Library,
  34. 34
    A Hróbjartsson, PC Gøtzsche, Placebo treatment versus no treatment, The Cochrane Library,
  35. 35
    MT Mellerup, K Krogsgaard, P Mathurin, C Gluud, T Poynard, Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B, The Cochrane Library,
  36. 36
    Martin Thyge Mellerup, Kim Krogsgaard, Philippe Mathurin, Christian Gluud, Thierry Poynard, Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B, The Cochrane Library,